
Medtech Startup MedVital Raises Rs 8.4 crore in Seed Funding

• MedVital has raised Rs 8.4 crore in a pre-seed funding round
• The startup's flagship, NoWound, is a compact, digitally enabled Negative Pressure Therapy
• MedVital plans to use the funding to enhance its product offerings
MedVital, a medtech startup of the new generation working towards making next-generation and innovative technologies for difficult-to-heal wounds and minimally invasive aesthetics smarter and more accessible, has raised 8.4 crore in a pre-seed round of funding.
The round has been led by Nihar Parikh's 4 point Health Ventures with participation from a marquee team of operator-investors comprising founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
MedVital is a cutting-edge medtech startup that claims to be creating India's first platform for integrated skin repair and restoration. The startup's flagship product, NoWound, is a cutting-edge Negative Pressure Wound Therapy (NPWT) device that promises precision-controlled healing in hospital, clinic, and home-care environments.
Different from traditional NPWT systems, NoWound is small in size, digitally enabled, and Indian-made, enabling easy deployment even in resource-poor environments, it added.
"MedVital was born with the conviction that repairing and restoring skin should be treated with the same degree of innovation and investment as any other high-priority field of medicine," stated Dr. Varun Gupta, Co-Founder and Chief Executive Officer of MedVital.
"We are building a full-stack platform that integrates clinically proven devices, intelligent monitoring, and next-generation biomaterials to transform how complex wounds are treated and how patients recover. Our goal is to become a trusted partner for specialists restoring a patient's skin, preventing diabetic amputations, or helping individuals regain confidence through aesthetic enhancements. Our mission is simple: to make advanced solutions accessible and fairly priced for everyone," Gupta added.
MedVital will use the new capital to enhance its product offerings, reinforce its supply chain, and expand its distribution network to tertiary care hospitals, rural clinics, and home-care.
"Our ambition is to establish India as a global center for innovation in wound care and skin restoration solutions. This investment provides us with the fuel to grow responsibly, developing a system that not only works in ICUs but also in homes and clinics across the country," said Tarun Bansal, Co-Founder and COO.
The company will also introduce liquid chitosan-based dressings for difficult-to-heal wounds in the near future and enter into dermal and hair regeneration solutions, opening up new clinical routes in both therapeutic and aesthetic treatments.
"MedVital's strategic methodology in hard-to-heal wound care and minimally invasive procedures places them distinctly within the healthcare industry. Their emphasis on enhancing accessibility of high-value science supported by quantifiable clinical results targets precisely what the market is clamoring for," noted Nihar Parikh, Founder of 4point0 Health Ventures.
• The startup's flagship, NoWound, is a compact, digitally enabled Negative Pressure Therapy
• MedVital plans to use the funding to enhance its product offerings
MedVital, a medtech startup of the new generation working towards making next-generation and innovative technologies for difficult-to-heal wounds and minimally invasive aesthetics smarter and more accessible, has raised 8.4 crore in a pre-seed round of funding.
The round has been led by Nihar Parikh's 4 point Health Ventures with participation from a marquee team of operator-investors comprising founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
MedVital is a cutting-edge medtech startup that claims to be creating India's first platform for integrated skin repair and restoration. The startup's flagship product, NoWound, is a cutting-edge Negative Pressure Wound Therapy (NPWT) device that promises precision-controlled healing in hospital, clinic, and home-care environments.
Different from traditional NPWT systems, NoWound is small in size, digitally enabled, and Indian-made, enabling easy deployment even in resource-poor environments, it added.
"MedVital was born with the conviction that repairing and restoring skin should be treated with the same degree of innovation and investment as any other high-priority field of medicine," stated Dr. Varun Gupta, Co-Founder and Chief Executive Officer of MedVital.
"We are building a full-stack platform that integrates clinically proven devices, intelligent monitoring, and next-generation biomaterials to transform how complex wounds are treated and how patients recover. Our goal is to become a trusted partner for specialists restoring a patient's skin, preventing diabetic amputations, or helping individuals regain confidence through aesthetic enhancements. Our mission is simple: to make advanced solutions accessible and fairly priced for everyone," Gupta added.
MedVital will use the new capital to enhance its product offerings, reinforce its supply chain, and expand its distribution network to tertiary care hospitals, rural clinics, and home-care.
"Our ambition is to establish India as a global center for innovation in wound care and skin restoration solutions. This investment provides us with the fuel to grow responsibly, developing a system that not only works in ICUs but also in homes and clinics across the country," said Tarun Bansal, Co-Founder and COO.
The company will also introduce liquid chitosan-based dressings for difficult-to-heal wounds in the near future and enter into dermal and hair regeneration solutions, opening up new clinical routes in both therapeutic and aesthetic treatments.
"MedVital's strategic methodology in hard-to-heal wound care and minimally invasive procedures places them distinctly within the healthcare industry. Their emphasis on enhancing accessibility of high-value science supported by quantifiable clinical results targets precisely what the market is clamoring for," noted Nihar Parikh, Founder of 4point0 Health Ventures.